Building on prior findings that stearidonic acid (SDA) sensitizes prostate cancer cells to taxanes via NF-κB inhibition, we evaluated its effect on cisplatin toxicity in ovarian cancer. The gene discussed is NFKB1; the disease is prostate cancer.